Sarepta Therapeutics
SRPT
SRPT
337 hedge funds and large institutions have $2.23B invested in Sarepta Therapeutics in 2026 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 109 increasing their positions, 127 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
2% less funds holding
Funds holding: 343 → 337 (-6)
14% less repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 127
Holders
337
Holding in Top 10
1
Calls
$102M
Puts
$105M
Top Buyers
| 1 | +$75.5M | |
| 2 | +$41.6M | |
| 3 | +$41.5M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$17.3M |
| 5 |
Morgan Stanley
New York
|
+$13.2M |
Top Sellers
| 1 | -$26.4M | |
| 2 | -$20.6M | |
| 3 | -$8.63M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$7.52M |
| 5 |
HF
HRT Financial
New York
|
-$5.69M |